INTRODUCTION
Benzimidazole and its derivatives have a long history as antimicrobial agents. Synthesis of benzimidazoles fused to another heterocyclic ring has attracted widespread attention due to their diverse application as antibacterial-, antiviral-, antitumorial-and anti-inflammatory agents (1) (2) (3) (4) (5) (6) (7) . Also, it was confirmed to have a moderate in vitro anti-HIV activity (8, 9) . In recent years, transition metal complexes bearing benzimidazoles have been reported to show activity against a number of microorganisms (10) (11) (12) (13) (14) (15) . It was found that the complexes of transition metal salts with benzimidazole derivatives showed a higher antimicrobial activitiy than ligands themselves.
As an extension of our previous studies (11) (12) (13) (14) (15) , the objective of the present work was to synthesize and study antimicrobial activities of 2-methylbenzimidazole derivatives and their zinc(II) complexes. Antimicrobial activities of the ligands and their complexes were evaluated against some test microorganisms.
EXPERIMENTAL

Reagents
All chemicals used to prepare the ligands and complexes were of analytical reagent grade, commercially available from different sources. The ligands were synthesized as described in the literature (15) .
Synthesis of complexes
All the complexes were prepared following the same procedure. A solution of 5 mmol of ZnCl 2 in 10 cm 3 of EtOH was added to a solution of 10 mmol of the ligand (2-me-
)) in 10 cm 3 EtOH. The resulting mixture was boiled under reflux on a water bath for about 2 h and then cooled. The complexes were separated from the reaction mixture by filtration, washed with EtOH and dried in vacuo over CaCl 2 .
Antimicrobial investigations
Antimicrobial activities of the ligands and their complexes were evaluated against three gram positive bacterial strains: Bacillus sp., Staphylococcus aureus and Sarcina lutea, one gram negative isolate: Pseudomonas aeruginosa and yeast: Candida pseudotropicalis. The activity was tested by the disc-diffusion method under standard conditions using Mueller-Hinton agar medium as described by NCCLS (16) . Each of the investigated isolates of bacteria was seeded in the tubes with nutrient broth (NB). It was taken 1 cm 3 of seeded NB and homogenized in tubes with 9 cm 3 of melted (45 o C) nutrient agar (NA). The homogenous suspension was poured out in Petri dishes. The discs of filter paper (diameter 5 mm) were ranged on cool medium. After cooling on formed solid medium, 2⋅10 -5 dm 3 of the investigated compound (γ=1000µg/ml) were placed by micropipette. After incubation for 24 hours in a thermostat at 25-27 o C, inhibition (sterile) zone diameters (including disc) were measured and expressed in mm. Inhibition zone diameter over 8 mm indicates the tested compound is active against microorganisms under investigation. Each test was done in three replications. In parallel with antimicrobial investigations of the complexes, ligands were tested too.
Minimum inhibitory concentration (MIC) was assessed by the agar dilution method according to guidelines established by the NCCLS standard M7-A5 (17). MIC was described as the lowest concentration of the compound that visibly inhibited colony growth. Stock solutions of the compounds were prepared in dimethylformamide (DMF). Further dilutions were performed with distilled water. The concentration range of the compounds tested was between 60-750µg/ml in two-fold dilution steps. The inoculated plates were then incubated at 35 o C for 16-20h.
RESULTS AND DISCUSSION
The antimicrobial activity of the 2-methylbenzimidazole derivatives and their zinc(II) complexes was first tested by the agar disc-diffusion method against gram-positive and gram-negative bacteria and yeast. The results of these studies are summarized in Table 1 .
As can be seen from Table 1 , the majority of the investigated compounds displayed in vitro antimicrobial activity against very persistent microorganisms. The starting ligand, 2-methylbenzimidazole (L 1 ), as well as its zinc(II) complex, showed no antimicrobial activity against yeast and gram-positive strains of bacteria. These compounds were found to be only active against gram-negative Pseudomonas aeruginosa. It may be concluded that the antimicrobial activity of these compounds is related to cell wall structure of the bacteria.
It is clear from the data, that none of the compounds was significantly effective against yeast Candida pseudotropicalis, except for 1-(4-methylbenzyl)-2-methylbenzimidazole(L , with a MIC value of 125µg/ml against Staphylococcus aureus and Sarcina lutea. On the other hand, the zinc(II) complex was more active than the starting ligand L 3 against Staphylococcus aureus and Sarcina lutea with a MIC value of 60µg/ml. In the case of Bacillus sp. ligand L 3 was equally active as its complex, with a MIC value of 125µg/ml. In the case of Pseudomonas aeruginosa the MIC value of [Zn(L 3 ) 2 Cl 2 ] was 60µg/ml, as well as 125µg/ml for L 3 . Of the tested ligands and their zinc(II) complexes, the most active compound was the complex of 1-(4-methylbenzyl)-2-methylbenzimidazole(L 3 ), which exhibited high inhibitory activity against all the tested bacteria isolates. It can be seen that some of the complexes were more active than the starting ligand. In view of the structural formula of the complexes that exhibited antimicrobial activity, it can be thought that metal may play a significant role. This can be explained in terms of chelation theory, which states that a decrease in the polarizability of the metal can enhance the lipophilicity of the complexes (12) .
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Comparing the activities of the tested ligands, it was found that if the benzimidazole nucleus was substituted with a 4-methylbenzyl group at the N1 atom, the antimicrobial activity was increased (12) . Consideration of the structural formula of the compounds that exhibit antimicrobial activity, substituted ligands and zinc moiety may play a role in the antimicrobial activity. The antimicrobial potency of the investigated benzimidazole derivatives is similar to that of different benzimidazoles, which were determined in the previous studies (1-4, 12,13) . CONCLUSIONS Zinc(II) chloride reacts with 2-methylbenzimidazole derivatives to give complexes of the formula ZnL 2 Cl 2 ·nH 2 O, where L=2-methylbenzimidazole, 1-benzyl-2-methylbenzimidazole and 1-(4-methylbenzyl)-2-methylbenzimidazole, n=0, 0.5 or 1. All the ligands and their zinc(II) complexes were evaluated for their in vitro antimicrobial activity against Pseudomonas aeruginosa, Bacillus sp., Staphylococcus aureus, Sarcina lutea and Candida pseudotropicalis. It is found that the starting ligand, 2-methylbenzimidazole, as well as its zinc(II) complex showed no antimicrobial activity against yeast and gram-positive strains of bacteria. These compounds were found to be only active against gram-negative Pseudomonas aeruginosa. Of the tested ligands and their zinc(II) complexes, the most active compound was the complex of 1-(4-methylbenzyl)-2-methylbenzimidazole, which exhibited high inhibitory activity against all the tested bacteria isolates. It can be seen that some of the complexes were more active than the starting ligand. In view of the structural formula of the complexes that exhibited antimicrobial activity it can be thought that metal may play a significant role. This can be explained in terms of chelation theory, which states that a decrease in the polarizability of the metal can enhance the lipophilicity of the complexes. Comparing the activities of the tested ligands, it was found that if the benzimidazole nucleus was substituted with a 4-methylbenzyl group at the N1 atom, the antimicrobial activity was increased. Consideration of the structural formula of the compounds that exhibit antimicrobial activity, substituted ligands and zinc moiety may play a role for the antimicrobial activity.
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показује значајнију активност на раст квасца Candida pseudotropicalis. За све лиганде и њихове комплексе одређена је минимална инхибиторна концентрација (МИК) и дискутован утицај структуре лиганада и комплекса на њихову антимикробну актив-ност.
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